Premium
Cutaneous reactions in hairy cell leukaemia treated with 2‐chlorodeoxyadenosine and allopurinol
Author(s) -
Chubar Yevgene,
Bennett Michael
Publication year - 2003
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2003.04506.x
Subject(s) - allopurinol , medicine , concomitant , cladribine , hairy cell leukemia , nucleoside analogue , purine nucleoside phosphorylase , purine analogue , dermatology , chemotherapy , nucleoside , leukemia , purine , chemistry , enzyme , biochemistry
Summary. The purine nucleoside analogue 2‐chlorodeoxyadenosine (2‐CdA) is currently considered by many as first‐line therapy for hairy cell leukaemia. Cutaneous reactions have occasionally been reported with this drug, particularly if used with allopurinol. We report a high frequency of skin reactions in 15 consecutive patients with hairy cell leukaemia treated with 17 courses of 2‐CdA. These reactions occurred only in those receiving allopurinol and, in two patients, were severe enough to warrant steroid therapy. The routine concomitant use of allopurinol is therefore not recommended in this setting.